Comparison of spread of subarachnoid sensory block and incidence of hypotension in early and late second trimester of pregnancy

Mi Hyeon Lee, Hee Jeong Son, Sang Hoon Lee, Jeong-Hyun Lee, Mi Hwa Chung, Young Ryong Choi, Eun Mi Choi, Mi Hyeon Lee, Hee Jeong Son, Sang Hoon Lee, Jeong-Hyun Lee, Mi Hwa Chung, Young Ryong Choi, Eun Mi Choi

Abstract

Background: Obstetric or non-obstetric surgery can be performed in pregnant women during the second trimester. We evaluated maximal sensory block level (MSBL), and other sensory block characteristics after spinal anesthesia in early and late second trimester pregnant women.

Methods: Forty-four pregnant women scheduled for cervical cerclage under spinal anesthesia in the early second trimester (Group E) or in the late second trimester (Group L) were enrolled in this study. Spinal anesthesia was performed at the L3/4 and 7 mg of 0.5% hyperbaric bupivacaine was injected into the subarachnoid space. Hemodynamic variables, incidence of nausea/vomiting, ephedrine dose, and sensory block were recorded every 2.5 min during the first 15 min and 20 min after the injection. The MSBL, the time at which MSBL was achieved, and the time to the two-segment regression of the sensory level were also recorded.

Results: The maximum number of segments blocked was significantly greater in the Group L than in the Group E. The incidence of nausea/vomiting and hypotension, and dose of administrated ephedrine were significantly higher in the Group L than in the Group E. The mean arterial pressure during the 15 min after subarachnoid injection was significantly lower compared to the baseline value in the Group L.

Conclusions: The MSBL of spinal anesthesia with hyperbaric bupivacaine 7 mg were T9 in the early and T5 in the late second trimester groups. Pregnant women in the late second trimester exhibited increased incidence of hypotension and need for ephedrine than women in the early second trimester.

Keywords: Bupivacaine; Pregnancy; Second trimester.

Figures

Fig. 1
Fig. 1
Number of dermatomes blocked in the early (Group E) and late (Group L) second trimester of pregnant at 2.5, 5, 7.5, 10, 12.5, 15 and 20 minutes after subarachnoid injection of 7 mg of 0.5% bupivacaine. *P < 0.05. Data represent mean ± SD. Dermatome 1 = L3; 4 = T12; 8 = T8; 12 = T4 of sensory block level.
Fig. 2
Fig. 2
Changes in mean arterial pressure (MAP, A) and heart rate (HR, B) after subarachnoid injection of 7 mg of 0.5% bupivacaine in the early (Group E) and late (Group L) second trimester of pregnant. Data represent mean ± SD. *P < 0.05 compared with baseline value in each group.

References

    1. Birnbach DJ, Brown IM. Anesthesia for obstetrics. In: Miller RD, editor. Miller's Anesthesia. Philadelphia: Elsevier/Churchill Livingstone; 2005. p. 2324.
    1. Higuchi H, Hirata J, Adachi Y, Kazama T. Influence of lumbosacral cerebrospinal fluid density, velocity, and volume on extent and duration of plain bupivacaine spinal anesthesia. Anesthesiology. 2004;100:106–114.
    1. Lee GY, Kim CH, Chung RK, Han JI, Kim DY. Spread of subarachnoid sensory block with hyperbaric bupivacaine in second trimester of pregnancy. J Clin Anesth. 2009;21:482–485.
    1. Barclay DL, Renegar OJ, Nelson EW., Jr The influence of inferior vena cava compression on the level of spinal anesthesia. Am J Obstet Gynecol. 1968;101:792–800.
    1. Bromage PR. Continuous lumbar epidural analgesia for obstetrics. Can Med Assoc J. 1961;85:1136–1140.
    1. Hirabayashi Y, Shimizu R, Fukuda H, Saitoh K, Furuse M. Anatomical configuration of the spinal column in the supine position II Comparison of pregnant and non-pregnant women. Br J Anaesth. 1995;75:6–8.
    1. Igarashi T, Hirabayashi Y, Shimizu R, Saitoh K, Fukuda H, Suzuki H. The fiberscoptic findings of the epidural space in pregnant women. Anesthesiology. 2000;92:1631–1636.
    1. Marx G, Bassell G. Physiologic considerations of the mother. In: Marx G, Bassell G, editors. Obstetric Analgesia and Anesthesia. New York: Elsevier/North-Holland; 1980. pp. 21–54.
    1. Greene NM. Distribution of local anesthetic solutions within the subarachnoid space. Anesth Analg. 1985;64:715–730.
    1. Hirabayashi Y, Shimizu R, Saitoh K, Fukuda H. Cerebrospinal fluid progesterone in pregnant women. Br J Anaesth. 1995;75:683–687.
    1. Fagraeus L, Urban BJ, Bromage PR. Spread of epidural analgesia in early pregnancy. Anesthesiology. 1983;58:184–187.
    1. Datta S, Hurley RJ, Naulty JS, Stern P, Lambert DH, Concepcion M, et al. Plasma and cerebrospinal fluid progesterone concentrations in pregnant and nonpregnant women. Anesth Analg. 1986;65:950–954.
    1. Bader AM, Datta S, Moller RA, Covino BG. Acute progesterone treatment has no effect on bupivacaine-induced conduction blockade in the isolated rabbit vagus nerve. Anesth Analg. 1990;71:545–548.
    1. Capeless EL, Clapp JF. Cardiovascular changes in early phase of pregnancy. Am J Obstet Gynecol. 1989;161:1449–1453.
    1. Clapp JF, 3rd, Seaward BL, Sleamaker RH, Hiser J. Maternal physiologic adaptations to early human pregnancy. Am J Obstet Gynecol. 1988;159:1456–1460.
    1. Logan MR, Drummond GB. Spinal anesthesia and lumbar lordosis. Anesth Analg. 1988;67:338–341.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj